Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-001860
Filing Date
2025-03-14
Accepted
2025-03-14 16:20:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3305
  Complete submission text file 0001950047-25-001860.txt   4765
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Subject) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-42121 | Film No.: 25740292
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RAPPORT THERAPEUTICS 1325 BOYLSTON ST., SUITE 401 BOSTON MA 02215
Business Address
Bredt David (Reporting) CIK: 0002022087 (see all company filings)

Type: 144